Home
/
AMICUS THERAPEUTICS, INC. (FOLD)
Stock Analysis
AMICUS THERAPEUTICS, INC. (FOLD)
14.49
+0.00%
Updated: 2026-06-16 10:37 UTC
Technology-style analysis layer: price structure, momentum, key levels and business quality in one view.
WOI Investment Thesis
Constructive
Momentum: Neutral
Range: 100% of 52W range
Bull—
Base14.49
Bear14.40
Key Levels
Resistance—
Support14.40
Invalidationlosing 14.26 would weaken the current structure.
Upside Target—
Analyst Narrative
The latest close for AMICUS THERAPEUTICS, INC. (FOLD) came in at 14.49 (+0.00%). Trend remains constructive above MA50 and MA200. Momentum stays positive (+0.56%), with 52W position: 100% of range, while Volatility: ATR14 0.11%. RSI(14) is 72.1, which reflects strong upside momentum, although the indicator is approaching stretched territory. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side.
🎯
Key levels:
Initial downside support sits near 14.40.
•
Holding that area would help preserve the current chart structure.
Technical Setup
🔺 Technical Setup
Breakout Watch
Downtrend line not broken yet · score 0
🎯 Decision Map
From a roadmap perspective, the setup is boxed by support near 14.26 and resistance around 15.47. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Business Lens
💼 Fundamentals Snapshot
Source: sec
💼 Business Lens
QUALITY VIEW
Financial quality snapshot
Financial context is mixed
📈 Growth: Strong
💰 Profit: Improving
💵 Cash: Mixed
🛡 Balance: Stretched
• Quarterly revenue growth remains strong and still points upward.
• Quarterly profitability is improving as earnings recover from an earlier soft patch.
🏢 Company
AMICUS THERAPEUTICS, INC.
Compare with related stocks
Same sector and industry ideas for deeper research
Note: This is an algorithmic technical snapshot, not financial advice.